✦ LIBER ✦

PRM160 A New Value-Based Pricing Framework for the Optimal Pricing of Pharmaceutical Assets

✍ Scribed by Hawryluk, E.A.; Malhotra, M.; Chawla, V.; Doyle, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The expected value of sample information

✍ Watson, P.; Brennan, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

The revenue risk of value-based pricing

✍ John D. Anderson; Kimberly A. Zeuli 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 95 KB

PR2 Value-Based Pricing in the UK: Devel

✍ C. Easley; J. Tang 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Value-based pricing: time for a NICEr wa

✍ Henry Lee; Dominic King; Ara Darzi; Paul Dolan 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 64 KB

The development of a value based pricing

✍ George Dranitsaris; Ilse Truter; Martie S. Lubbe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 157 KB

PCN78 THE DEVELOPMENT OF A VALUE BASED P

✍ G. Dranitsaris; I. Truter; M. Lubbe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB